CLASS II Device recall · Reported 25 Mar 2015 · FDA Enforcement Report

BD Posiflush Saline Flush Syringe inlcuded recalled

Bard Access Systems is recalling BD Posiflush Saline Flush Syringe inlcuded in the following device kits: Groshong Midline, distributed nationwide in the US. The recall was initiated on 8 Aug 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 13FB8860 Product codes: CK000069
Quantity recalled48 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1275-2015
FDA event ID
70430
Recalling firm
Bard Access Systems, Salt Lake City, UT
Classification
Class II
Status
Terminated
Recall initiated
8 Aug 2014
FDA classified
13 Mar 2015
Reported
25 Mar 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

8 Aug 2014Recall initiated by company
13 Mar 2015Classified by FDA+217 days
25 Mar 2015Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Some unit packages of BD PosiFlush SF Saline Flush Syringe 10 mL may exhibit open seals, which could impact product sterility. Bard includes these pouched syringes, attached to some configurations of PICC kits, Port Access kits (PAK), PowerGlide kits, Midline kits, and Convenience kits.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

BD Posiflush Saline Flush Syringe 10 ml inlcuded in the following device kits: Groshong Midline Bard MYPICC Kit 4F (Single-Lumen) The syringe is used to pre-flush the catheter prior to placement and may also be used to verify patency post-placement.

Where it was distributed

US Nationwide Distribution.

Nationwide

Questions about this recall

Is BD Posiflush Saline Flush Syringe inlcuded in the following device kits: Groshong Midline recalled?

Yes. Bard Access Systems recalled BD Posiflush Saline Flush Syringe inlcuded in the following device kits: Groshong Midline on 8 Aug 2014. The recall is Class II and its status is Terminated. Recall number Z-1275-2015.

Why was it recalled?

Some unit packages of BD PosiFlush SF Saline Flush Syringe 10 mL may exhibit open seals, which could impact product sterility. Bard includes these pouched syringes, attached to some configurations of PICC kits, Port Access kits (PAK), PowerGlide kits, Midline kits, and Convenience kits.

Which lots are affected?

Lot Numbers: 13FB8860 Product codes: CK000069

Where was it sold?

US Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bard Access Systems

All 63

Other Heart & Vascular Devices recalls

All 6,199